SENIOR LEADERSHIP

项目概要（见说明）：芝加哥大学综合癌症中心（UCCCC）由一个强大的领导团队领导，该团队有效地代表了参与癌症研究和临床护理的学术单位的所有组成部分，并将基础，临床，转化和人口研究计划紧密联系在一起。高级领导包括2名联席副主任和7名副主任。在过去的5年里，领导层的战略变化促进了癌症项目综合和共同愿景的发展。新的任命，加上领导层的相当连续性，加强了组织和规划能力。Richard Schilsky，MD（血液学/肿瘤科科长）取代Vokes博士（被任命为医学主席）担任临床科学联合副主任。他与玛莎罗斯纳密切合作，博士（主席，本梅癌症研究部）谁仍然是基础科学的联合副主任。基础科学副主任（Geoffrey格林，博士，Ben May癌症研究部副主任），临床科学（Mark Ratain，医学博士，医学教授，个性化治疗中心主任）和人口研究（Habibul Ahsan，MBBS，MMedSc，健康研究教授，癌症流行病学和预防中心主任），都被公认为各自领域的领导者，继续他们的角色。Marcy List博士继续担任行政副主任。James Schilling博士是一位经验丰富的研究人员，拥有蛋白质组学方面的专业知识，现在担任核心设施副主任和BSD共享研究设施办公室的执行主任。2011年，UCCCC设立了两个新职位，转化科学副主任（Ravi Salgia，MD，PhD，医学教授，转化研究副主席，系主任）。医学副教授）和教育副主任（医学博士Ezra Cohen，医学副教授，血液学/肿瘤学奖学金计划主任）。上述人员是UCCCC执行委员会（EC）和癌症咨询委员会（CAC）的成员（核心设施副主任除外）。CAC还包括从事癌症研究和癌症患者护理的学术单位的其他领导人，例如。放射肿瘤学、外科肿瘤学、泌尿科和儿科血液学/肿瘤学。副主任和副主任与主任密切合作，负责战略规划，UCCCC的一般管理和实施其领域内的具体方案。他们共同负责确定和实施跨学科的努力，确定招聘需求，领导招聘搜索，优先分配UCCCC资源（包括有关试点项目奖励的最终决定），开发新的共享资源，并与项目领导人一起推进项目目标。在过去的一年里，该小组承担了制定UCCCC战略计划的主要责任。

PROJECT SUMMARY (See instructions): The University of Chicago Comprehensive Cancer Center (UCCCC) is led by a Strong Leadership Team, which effectively represents all components of the academic units Involved In cancer research and clinical care, and tightly links the basic, clinical, translational and population research programs. The Senior Leaders includes 2 Co-Deputy Directors and 7 Associate Directors. Over the past 5 years, strategic changes In the leadership have facilitated the development of an Integrated and shared vision for the cancer programs. New appointments, together with considerable continuity of leadership, have enhanced organizational and planning capabilities. Richard Schilsky, MD (Chief, Section of Hematology/ Oncology) replaced Dr. Vokes (who was appointed Chair of Medicine) as Co-Deputy Director for Clinical Sciences. He works closely with Marsha Rosner, PhD (Chair, Ben May Department for Cancer Research) who remains as the Co-Deputy Director for Basic Sciences. The Associate Directors for Basic Sciences (Geoffrey Greene, PhD, Vice Chair of the Ben May Department for Cancer Research), Clinical Sciences (Mark Ratain, MD, Professor of Medicine, Director, Center for Personalized Therapeutics), and Population Research (Habibul Ahsan, MBBS, MMedSc, Professor of Health Studies, Director, Center for Cancer EpWemiology and Prevention), all recognized as leaders in their fields, continue in their roles. Marcy List, PhD, continues in her role as Associate Director for Administration. James Schilling, PhD, an experienced investigator with expertise in proteomics, now serves as the Associate Director for Core Facilities, and Executive Director of the BSD Office of Shared Research Facilities. In 2011, the UCCCC created two new positions, the Associate Director for Translational Sciences (Ravi Salgia, MD, PhD, Professor of Medicine, Vice Chair for Translational Research, Dept. of Medicine) and the Associate Director for Education (Ezra Cohen, MD, Associate Professor of Medicine, Director of the Hematology/Oncology Fellowship Program). The above individuals are members (with the exception of the Associate Director for Core Facilities) of the UCCCC Executive Committee (EC) and the Cancer Advisory Committee (CAC). The CAC also includes additional leaders of academic units engaged In cancer research and care of patients with cancer, e.g.. Radiation Oncology, Surgical Oncology, Urology and Pediatric Hematology/Oncology. The Deputy Directors and Associate Directors, work closely with the Director, and are responsible for strategic planning, general administration of the UCCCC and Implementation of specific programs within their areas. Together they are responsible for identifying and implementing interdisciplinary efforts, identifying recruitment needs, leading recruitment searches, prioritizing allocation of UCCCC resources (including final decisions about the Pilot Project awards), developing new shared resources, and worthing with the Program Leaders In advancing programmatic goals. Over the past year, this group has taken primary responsibility for developing the UCCCC Strategic Plan.